DE69214647D1 - Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz - Google Patents

Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz

Info

Publication number
DE69214647D1
DE69214647D1 DE69214647T DE69214647T DE69214647D1 DE 69214647 D1 DE69214647 D1 DE 69214647D1 DE 69214647 T DE69214647 T DE 69214647T DE 69214647 T DE69214647 T DE 69214647T DE 69214647 D1 DE69214647 D1 DE 69214647D1
Authority
DE
Germany
Prior art keywords
atipamezol
male sexual
sexual impotence
treating male
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69214647T
Other languages
English (en)
Other versions
DE69214647T2 (de
Inventor
Antti Pertovaara
Ilkka Linnankoski
Raimo Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Publication of DE69214647D1 publication Critical patent/DE69214647D1/de
Application granted granted Critical
Publication of DE69214647T2 publication Critical patent/DE69214647T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69214647T 1991-06-18 1992-06-18 Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz Expired - Fee Related DE69214647T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113077A GB9113077D0 (en) 1991-06-18 1991-06-18 Use of atipamezole
PCT/FI1992/000191 WO1992022296A1 (en) 1991-06-18 1992-06-18 Use of atipamezole for the treatment of male sexual impotence

Publications (2)

Publication Number Publication Date
DE69214647D1 true DE69214647D1 (de) 1996-11-21
DE69214647T2 DE69214647T2 (de) 1997-02-20

Family

ID=10696833

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214647T Expired - Fee Related DE69214647T2 (de) 1991-06-18 1992-06-18 Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz

Country Status (21)

Country Link
EP (1) EP0589957B1 (de)
JP (1) JP3151217B2 (de)
KR (1) KR100324447B1 (de)
AT (1) ATE144141T1 (de)
AU (1) AU661698B2 (de)
CA (1) CA2102187C (de)
CZ (1) CZ284409B6 (de)
DE (1) DE69214647T2 (de)
DK (1) DK0589957T3 (de)
ES (1) ES2092685T3 (de)
GB (1) GB9113077D0 (de)
GR (1) GR3021677T3 (de)
HU (1) HU220068B (de)
IE (1) IE921735A1 (de)
IL (1) IL101961A (de)
MX (1) MX9202948A (de)
NO (1) NO304011B1 (de)
NZ (1) NZ242863A (de)
RU (1) RU2111749C1 (de)
WO (1) WO1992022296A1 (de)
ZA (1) ZA923961B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä

Also Published As

Publication number Publication date
JPH06508350A (ja) 1994-09-22
NZ242863A (en) 1997-06-24
AU661698B2 (en) 1995-08-03
ATE144141T1 (de) 1996-11-15
CZ284409B6 (cs) 1998-11-11
GB9113077D0 (en) 1991-08-07
WO1992022296A1 (en) 1992-12-23
JP3151217B2 (ja) 2001-04-03
GR3021677T3 (en) 1997-02-28
RU2111749C1 (ru) 1998-05-27
ZA923961B (en) 1993-02-24
CZ248793A3 (en) 1994-04-13
NO304011B1 (no) 1998-10-12
IL101961A (en) 1995-12-31
AU1972492A (en) 1993-01-12
EP0589957A1 (de) 1994-04-06
CA2102187A1 (en) 1992-12-19
CA2102187C (en) 2003-03-11
HUT65817A (en) 1994-07-28
HU220068B (hu) 2001-10-28
KR100324447B1 (ko) 2002-06-20
MX9202948A (es) 1993-04-01
NO934690D0 (no) 1993-12-17
IE921735A1 (en) 1992-12-30
NO934690L (no) 1993-12-17
EP0589957B1 (de) 1996-10-16
DE69214647T2 (de) 1997-02-20
IL101961A0 (en) 1992-12-30
DK0589957T3 (da) 1996-11-18
ES2092685T3 (es) 1996-12-01

Similar Documents

Publication Publication Date Title
DE69319270T2 (de) Verfahren zur Behandlung von organischen Schlämmen
ATE189121T1 (de) Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion
DE69124293T2 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
DE69938179D1 (de) Kombination von riluzol und levodopa zur behandlung von morbus parkinson
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE3873855T2 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE69404725T2 (de) Verfahren zur elektrolytischen Behandlung von Altbatterien
DE69214647D1 (de) Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz
IT9086204A0 (it) Metodo per la cura dell'impotenza erettiva maschile
DK664188A (da) Butylhydroxyanisoler til behandling af retrovirale sygdomme
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
RU93058537A (ru) Применение атипамезола для лечения мужской сексуальной импотенции
DE9307108U1 (de) Vorrichtung zur Behandlung von Zahnfehlstellungen
DE69413325D1 (de) 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis
ATE79541T1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee